Markets
Both contracts last week posted their biggest weekly gains in three weeks on cuts in US oil production and diplomatic tensions in the Middle East.
15 Jul 2019 11:00 AM

Brent crude futures for September fell 21 cents to USD 66.51 a barrel.

Easing crude oil prices and positive opening in domestic equities supported the rupee.
15 Jul 2019 10:12 AM

Rupee is trading at 68.53 against dollar, driven by positive opening in domestic equities and easing crude oil prices.

The broader Nifty rose 46.95 points, or 0.41 per cent, to 11,599.45.
15 Jul 2019 10:08 AM

The 30-share index, however, gave up some gains to trade 164.84 points, or 0.43 per cent, higher at 38,901.07.

Investors will now focus on the upcoming quarter result, where expectation remains to be muted cautioning investors.
15 Jul 2019 1:39 AM

Sentiments were hit by sharp rise in crude prices and geopolitical tensions as well as trade war worries.

The financial performance of the sector is expected to remain under stress as traditional brokers like Axis Securities and Angel Broking have moved to fixed/subscription based business models.
15 Jul 2019 1:23 AM

Traditional brokers find going tough even after cutting fee.

HDFC Bank's valuation plummeted Rs 22,395.4 crore to Rs 6,54,084.95 crore.
14 Jul 2019 2:43 PM

RIL was the lone gainer among the top-10 frontline companies, adding Rs 11,415.21 crore to its m-cap.

Markets may also react to macroeconomic data released after market hours Friday.
14 Jul 2019 11:38 AM

Investors will also monitor trade-related developments, as well movement in the rupee and crude oil prices, they added.

As per the latest depositories data, FPIs withdrew a net sum of Rs 4,953.77 crore from equities during July 1-12, but poured in a net Rs 8,504.78 crore into the debt market, translating into a cumulative net investment of Rs 3,551.01 crore. (Photo: Representational | PTI)
14 Jul 2019 11:28 AM

FPIs pulled out money from equity markets for five of the six sessions following the Budget, which was presented on July 5.

Among the large-cap stocks, Cipla, Aurobindo Pharma, and Cadila will report better performance driven by their US businesses. Within mid-cap pharma companies, Alkem Laboratories, Abott India, Alembic Pharma are likely to deliver superior performance led by India revenues, said HDFC Securities.
13 Jul 2019 1:38 AM

Among the large-cap stocks, Cipla, Aurobindo Pharma, and Cadila will report better performance driven by their US businesses.

The data also said the Index of Industrial Production, or IIP, grew at 0.4 per cent in March this year.
13 Jul 2019 1:37 AM

The data also said the Index of Industrial Production, or IIP, grew at 0.4 per cent in March this year.